论文部分内容阅读
自1985年2月至1986年5月,作者用胎儿胸腺细胞悬液治疗急性非淋巴细胞白血病6例,5例获完全缓解,生存期较对照组明显延长。 胸腺治疗组6例,其中M_21例,M_33例,M_42例;男性4例,女性2例;年龄20～28岁。单纯化疗组8例为对照,其中M_13例,M_24例,M_41例;男性5例,女性3例;年龄17～59岁。两组均用以COAP或HOAP为主的化疗方案进行联合化疗。胸腺组于治疗过程中随机输注胎儿胸腺细胞悬液。输注1～6次。化疗不足两疗程或中途出院不知转归者未计在
From February 1985 to May 1986, the authors used fetal thymocyte suspension in the treatment of acute non-lymphocytic leukemia in 6 cases, 5 cases were completely relieved, the survival time was significantly longer than the control group. Thymus treatment group 6 cases, including M_21 cases, M_33 cases, M_42 cases; 4 males and 2 females; aged 20 to 28 years. 8 cases of chemotherapy alone group as a control, including M_13 cases, M_24 cases, M_41 cases; 5 males and 3 females; aged 17 to 59 years. Both groups were given chemotherapy with COAP or HOAP-based chemotherapy. The thymus group was randomly infused with fetal thymocyte suspension during the course of treatment. Infusion 1 to 6 times. Chemotherapy less than two courses or discharged halfway I do not know who are not included in the outcome